sciences investing alta partners is a leading venture capital firm in life sciences funding over 145 companies in the industry since 1996 . our diverse and integrated team brings together a powerful depth of knowledge and experience delivering tangible results for our companies and our investors . alta partners news january 11 2015the global healthcare exits report orbimed and alta partners figured most prominently in venture s best exits december 25 2014alta partners figures prominently among 2014 s largest us based vc backed healthcare exits september 08 2014healthcare s top venture capital firms portfolio news september 26 2016kite pharma announces positive topline kte c19 data from zuma 1 pivotal trial in patients with aggressive non hodgkin lymphoma nhl september 20 2016kite pharma announces exclusive license with the national institutes of health for multiple neoantigen directed t cell receptor tcr product candidates to treat solid tumors expressing mutated kras september 19 2016sutro adcs targeting cd74 suppress tumors in multiple malignant cell lines and animal models of multiple myeloma and non hodgkin lymphoma september 16 2016aerie pharmaceuticals raises 125 million in public offerings september 15 2016aerie pharmaceuticals announces public offering of common stock september 15 2016acelrx reports positive results for arx 04 sufentanil sublingual tablet 30 mcg including in elderly patients and patients with organ impairment in third phase 3 registration trial sap303 portfolio highlights january 17 20142013 alta partners portfolio highlights december 3 2013cbinsights ranks alta as one of the top three in value creation allakos carbylan therapeutics inc. kiadis pharma see our complete portfolio ... 1996 2016 alta partners